Deka Bank Deutsche Girozentrale Global Blood Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$25.68 - $35.59 $56,496 - $78,298	2,200 Added 9.98%	24,250 $848,000
Q4 2021 Feb 02, 2022	BUY	$24.9 - $40.26 $14,940 - $24,156	600 Added 2.8%	22,050 $659,000
Q4 2020 Mar 12, 2021	SELL	$37.65 - $63.77 $41,415 - $70,147	-1,100 Reduced 4.88%	21,450 $938,000
Q3 2020 Oct 29, 2020	BUY	$52.76 - $74.49 $1.19 Million - $1.68 Million	22,550 New	22,550 $1.2 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $1.3 Million - $1.66 Million	-28,600 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$52.6 - $63.29 $583,860 - $702,519	11,100 Added 63.43%	28,600 $1.54 Million
Q1 2019 May 10, 2019	BUY	$39.99 - $53.48 $127,968 - $171,136	3,200 Added 22.38%	17,500 $858,000
Q4 2018 Feb 12, 2019	SELL	$31.54 - $46.67 $100,928 - $149,344	-3,200 Reduced 18.29%	14,300 $571,000
Q3 2018 Nov 09, 2018	SELL	$38.0 - $51.1 $19,000 - $25,550	-500 Reduced 2.78%	17,500 $0
Q1 2018 May 03, 2018	BUY	$39.6 - $65.9 $419,760 - $698,540	10,600 Added 143.24%	18,000 $859,000
Q3 2017 Nov 06, 2017	BUY	$25.1 - $31.05 $185,740 - $229,770	7,400	7,400 $212,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.